Request Deal Involvement
VERAXA Biotech completed the acquisition of Synimmune from KfW for €32m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
Valency Communications
legal advisors
Lenz & Staehelin
or
Principals
target
SYNIMMUNE
bidder
VERAXA BIOTECH
vendor
KFW GROUP
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite